China Resources Boya Bio pharmaceutical Group Co Ltd (300294)

Currency in CNY
27.20
+0.30(+1.12%)
Closed·

300294 Financial Summary

Key Ratios

P/E Ratio35.7
Price/Book1.81
Debt / Equity0.15%
Return on Equity5.09%
Dividend Yield1.18%
EBITDA519.84M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of CNY (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.77%
Dividend Yield
1.18%
Industry Median 1.51%
Annualised payout
0.32
Paid annually
5-Years Growth
+16.36%
Growth Streak

Analyst Ratings

5 Buy
2 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 32.88
(+20.86% Upside)

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
0.28 / 0.27
Revenue / Forecast
535.88M / --
EPS Revisions
Last 90 days

FAQ

What were China Resources Boya Bio pharmaceutical's earnings for the latest quarter?

The China Resources Boya Bio pharmaceutical EPS (TTM) is 0.77. China Resources Boya Bio pharmaceutical reported sales of 535.88, net income of 139.48, and EPS of 0.28 for the latest quarter.

What was China Resources Boya Bio pharmaceutical's net income for the latest quarter?

China Resources Boya Bio pharmaceutical's net income for the latest quarter was 139.48.

How did China Resources Boya Bio pharmaceutical's performance compare year-over-year in the latest quarter?

The company's revenue moved from 489.80 in the previous quarter to 535.88 in the latest quarter, and net income moved from -15.71 to 139.48 compared to the previous quarter.

What is China Resources Boya Bio pharmaceutical's net profit margin on a TTM basis?

China Resources Boya Bio pharmaceutical's trailing twelve months (TTM) net profit margin is 22.88%.

How does China Resources Boya Bio pharmaceutical's debt to equity ratio compare to industry standards?

China Resources Boya Bio pharmaceutical's total debt-to-equity ratio is 0.15%.

What is China Resources Boya Bio pharmaceutical's return on investment on a TTM basis?

China Resources Boya Bio pharmaceutical's trailing twelve months (TTM) return on investment (ROI) is 5.09%.

Did China Resources Boya Bio pharmaceutical gain or lose cash last quarter?

In the latest quarter, China Resources Boya Bio pharmaceutical's net change in cash was -713.11 million.

What were China Resources Boya Bio pharmaceutical's total assets and liabilities in the latest quarter?

As of the latest quarter, China Resources Boya Bio pharmaceutical reported total assets of 8,478.71 million and total liabilities of 696.58 million.

How has China Resources Boya Bio pharmaceutical's total revenue grown this year?

China Resources Boya Bio pharmaceutical's total revenue was 489.80 in the previous quarter and 535.88 in the latest quarter.

What is China Resources Boya Bio pharmaceutical's gross margin on a TTM basis?

China Resources Boya Bio pharmaceutical's trailing twelve months (TTM) gross margin is 60.54%.

What was China Resources Boya Bio pharmaceutical's revenue per share for the latest quarter?

China Resources Boya Bio pharmaceutical's revenue per share for the latest quarter was 6.97.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.